MRCC to boost output ofgasoil with new unit

Platts Oilgram News Group

首页> 外文期刊>Platt's Oilgram News >MRCC to boost output ofgasoil with new unit

【24h】

MRCC to boost output ofgasoil with new unit

机译：MRCC通过新装置提高汽油产量

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Hong Kong-Sinopec's Maoming Refining andChemical Company expects to start commer-cial operations of a newly built gasoilhydrotreater at its 13.5 million mt/year(270,000 b/d) refinery in southern China'sGuangdong province in late August,an MRCCofficial said July 26.

机译：MRCC官员7月26日表示，香港-中国石化的茂名炼油与化学公司预计将于8月下旬在中国南部广东省的一座年产能为1350万吨/年（270,000桶/天）的炼油厂开始商业化运营。

著录项

来源
《Platt's Oilgram News》 |2006年第142期|共1页
作者
Platts Oilgram News Group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. MRCC to boost output ofgasoil with new unit [J] . Platts Oilgram News Group Platt's Oilgram News . 2006,第142期

机译：MRCC通过新装置提高汽油产量
2. Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group [J] . Marie-France Savard, Aaron R. Hansen, Marco A.J. Iafolla, The oncologist . 2020,第5期

机译：国际MRCC数据库联盟危险集团综合孙尼替尼患者综合细胞转移性肾细胞癌（MRCC）的临床结果对临床结果的真实评价
3. Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy? [J] . Amishi Y. Shah, Jose A. Karam, Zita D. Lim, Urology Case Reports . 2015,第2期

机译：舒尼替尼治疗转移性肾细胞癌（mRCC）患者的临床和病理学完全缓解：靶向治疗可治愈mRCC吗？
4. A solar powered single-inductor dual-output (SIDO) DC-DC boost for power management unit system with high light-load efficiency [C] . Lee Chuang, Chun-Chang Wu, Wei-Heng Wang, International Symposium on VLSI Design, Automation, and Test . 2017

机译：太阳能单电感双输出（SIDO）DC-DC升压，用于轻载效率高的电源管理单元系统
5. Sliding mode tracking control of output voltage in multiple modular DC-to-DC boost power converters. [D] . Patterson, Joe. 2007

机译：多个模块化DC-DC升压功率转换器中输出电压的滑模跟踪控制。
6. Real‐World Assessment of Clinical Outcomes Among First‐Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group [O] . Marie‐France Savard, J. Connor Wells, Jeffrey Graham, 2020

机译：国际mRCC数据库联合会风险小组对一线舒尼替尼一线透明细胞转移性肾细胞癌（mRCC）患者的临床疗效进行了真实世界评估
7. PCN22 CLINICAL HETEROGENEITY AMONG FIRST-LINE SUNITINIB PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) CATEGORIZED AS INTERMEDIATE RISK (IR) GROUP ACCORDING TO THE INTERNATIONAL MRCC DATABASE CONSORTIUM (IMDC) RISK MODEL [O] . L. Huynh, J.C. Wells, J. Graham, 2019

机译：PCN22根据国际MRCC数据库联盟（IMDC）风险模型，将一线仙硝尼患者（MRCC）分类为中间风险（IR）组的临床异质性

MRCC to boost output ofgasoil with new unit

摘要

著录项

相似文献

相关主题

期刊订阅